Correlation analysis of clinical parameters with epigenetic modifications in the DUX4 promoter in FSHD-Reference-Cited by-同舟云学术

Correlation analysis of clinical parameters with epigenetic modifications in the DUX4 promoter in FSHD

Published:2012-06 Issue:6 Volume:7 Page:579-584
ISSN:1559-2294
Container-title:Epigenetics
language:en
Short-container-title:Epigenetics

Author:

Balog Judit¹,Thijssen Peter E.¹,de Greef Jessica C.¹,Shah Bharati²,van Engelen Baziel G.M.³,Yokomori Kyoko⁴,Tapscott Stephen J.⁵,Tawil Rabi²,van der Maarel Silvère M.¹

Affiliation:

1. Department of Human Genetics; Leiden University Medical Center; Leiden, The Netherlands

2. Department of Neurology; University of Rochester Medical Center; Rochester, NY USA

3. Department of Neurology; Radboud University; Nijmegen Medical Center; Nijmegen, The Netherlands

4. Department of Biological Chemistry; School of Medicine; University of California; Irvine, CA USA

5. Division of Human Biology; Fred Hutchinson Cancer Research Center; Seattle, WA USA

Publisher

Informa UK Limited

Subject

Cancer Research,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.4161/epi.20001

Reference15 articles.

1. Padberg GW. Facioscapulohumeral disease. Leiden University, Leiden, 1982.

2. Clinical features of facioscapulohumeral muscular dystrophy 2

3. Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy

4. Specific Loss of Histone H3 Lysine 9 Trimethylation and HP1γ/Cohesin Binding at D4Z4 Repeats Is Associated with Facioscapulohumeral Dystrophy (FSHD)

5. Common epigenetic changes of D4Z4 in contraction-dependent and contraction-independent FSHD

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progesterone may be a regulator and B12 could be an indicator of the proximal D4Z4 repeat methylation status on 4q35ter;Journal of Neurochemistry;2024-08-06

2. Systemic Pharmacotherapeutic Treatment of the ACTA1-MCM/FLExDUX4 Preclinical Mouse Model of FSHD;International Journal of Molecular Sciences;2024-06-26

3. SMCHD1 has separable roles in chromatin architecture and gene silencing that could be targeted in disease;Nature Communications;2023-09-25

4. Facioscapulohumeral muscular dystrophy: the road to targeted therapies;Nature Reviews Neurology;2023-01-10

5. Update on the Molecular Aspects and Methods Underlying the Complex Architecture of FSHD;Cells;2022-08-29